BackAchieve Life Sciences Overview
Achieve Life Sciences Inc.

Achieve Life Sciences Target Price

Analysts' average 12-month price target for Achieve Life Sciences is $16.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.24

Average Target Price

$16.20123.8% upside

5 analysts in the last 4 months

High: $20 | Low: $12

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-29Stifel Nicolaus$18148.6% upsideOpen
2026-08-13Morgan StanleyMaxwell Skor$1379.6% upsideOpen
2026-08-12Raymond JamesRyan Deschner$18148.6% upsideOpen
2026-08-12H.C. WainwrightBrandon Folkes$1265.7% upsideOpen
2026-06-26Raymond James$20176.2% upsideOpen
2026-04-20Canaccord Genuity$1379.6% upsideOpen
2024-05-13OppenheimerFrancois Brisebois$5.524% downsideOpen
2022-11-16Maxim Group$444.8% downsideOpen

Achieve Life Sciences (ACHV) FAQ

The latest target price for ACHV is $16. Investors often review this figure alongside Achieve Life Sciences's historical trend and sector peers before judging valuation or financial health.

Achieve Life Sciences trades near $7.24 while the consensus target sits at $16 (123.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ACHV's target price ($16), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Achieve Life Sciences's target price against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.